ALL
61
-2
D
45
4
O
35
4
BLK
61
-2
COST
53
5
VLO
40
-2
LH
48
2
NWL
57
3
MO
57
4
CPB
37
2
DIS
72
2
PHM
43
2
GIS
54
2
GT
39
2
STZ
49
2
NKE
36
6
MAS
63
3
TGT
52
2
FSLR
60
-10
SIG
52
2
ALL
61
-2
D
45
4
O
35
4
BLK
61
-2
COST
53
5
VLO
40
-2
LH
48
2
NWL
57
3
MO
57
4
CPB
37
2
DIS
72
2
PHM
43
2
GIS
54
2
GT
39
2
STZ
49
2
NKE
36
6
MAS
63
3
TGT
52
2
FSLR
60
-10
SIG
52
2
Financhill
Back

RiverNorth Opportunities Fund Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
74

RIV
RiverNorth Opportunities Fund

Last Price:
$11.74
Seasonality Move:
-0.84%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.7200
Seasonality Move:
33.23%
Buy
74
RiverNorth Opportunities Fund (RIV) is a Buy

Is RiverNorth Opportunities Fund a Buy, Sell or Hold?

  • The current RiverNorth Opportunities Fund [RIV] share price is $11.69. The Score for RIV is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • RIV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RIV Stock Price Chart

What is RiverNorth Opportunities Fund's stock price today?

  • The RiverNorth Opportunities Fund share price today is $11.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIV is experiencing slight selling pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

RIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.89 Buy
Relative Strength Index (14 RSI): 50.66 Buy
Chaikin Money Flow: -18407 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.42 - 11.84) Buy
Bollinger Bands (100): (11.55 - 12.27) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

RIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.71 Sell
20-day SMA: 11.72 Sell
50-day SMA: 11.61 Buy
200-day SMA: 11.88 Sell
8-day EMA: 8.36 Buy
20-day EMA: 4.6 Buy
50-day EMA: 2.12 Buy
200-day EMA: 0.57 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

RiverNorth Opportunities Fund Earnings Growth & RIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

RiverNorth Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):